This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
New York-based Coty Inc., along with its subsidiaries, manufactures, markets, and distributes beauty products worldwide. The company sells its products through retailers, including hypermarkets, supermarkets, independent and chain drug stores and pharmacies, upscale perfumeries, upscale and mid-tier department stores, nail salons, specialty retailers, duty-free shops and traditional food, and drug and mass retailers. It also markets products under the Astor, Coty, Joop!, Jovan, Manhattan, and N.Y.C. New York Color brands.
Here's How Sanderson Farms (SAFM) Looks Ahead of Q3 Earnings
by Zacks Equity Research
Adverse impacts of coronavirus-induced costs as well as production cuts at food service plants are likely to get reflected in Sanderson Farms' (SAFM) third-quarter fiscal 2020 results.
Factors to Watch as Coty (COTY) Gears Up for Q4 Earnings
by Zacks Equity Research
Coty's (COTY) fourth-quarter fiscal 2020 results are likely to reflect coronavirus concerns like soft traffic and lower travel. Nonetheless, the e-commerce business has been trending well.
Analysts Estimate Coty (COTY) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Coty (COTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Do Options Traders Know Something About Coty (COTY) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Coty (COTY) stock based on the movements in the options market lately.
Corornavirus-Led Store Closures Hurt Inter Parfums' Q2 Sales
by Zacks Equity Research
Inter Parfums' (IPAR) sales decline year-over-year across all brands and geographies in second-quarter 2020, thanks to coronavirus-led store closures.
Coty's Turnaround Plans Robust, Consumer Beauty Unit Hurts
by Zacks Equity Research
Coty (COTY) is making solid efforts to bring a turnaround to its business. The company's Consumer Beauty segment has been soft for a while.
Estee Lauder's (EL) Robust E-commerce Business Bodes Well
by Zacks Equity Research
Estee Lauder (EL) is benefiting from impressive cost-saving efforts amid the pandemic. The company's robust digital sales are cushioning from the coronavirus outbreak-led store closures.
Implied Volatility Surging for Coty (COTY) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Coty (COTY) stock based on the movements in the options market lately.
Swap These 3 Coronavirus-Hit Losers With 3 Surprising Winners
by Urmimala Biswas
There are a number of stocks across industries, which continued to plummet even when the market received temporary kicks.
Coty (COTY) to Buy Stake in Kim Kardashian's Beauty Business
by Zacks Equity Research
Coty (COTY) announced its decision to buy 20% stake in Kim Kardashian's beauty business for $200 million.
Company News for Jun 30, 2020
by Zacks Equity Research
Companies in the news are: KNSA, TLSA, COTY, ICPT
Coty (COTY) Up 30.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Coty (COTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Implied Volatility Surging for Coty (COTY) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Coty (COTY) stock based on the movements in the options market lately.
Company News for June 2, 2020
by Zacks Equity Research
Companies in the news are: MYOV, ITRM, COTY, OPK
Coty (COTY) in Focus: Stock Moves 5.4% Higher
by Zacks Equity Research
Coty (COTY) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
5 Consumer Staple Stocks Set to Beat Earnings Despite Coronavirus
by Vrishali Bagree
Several players in the Consumer Staples sector have been benefiting from rising demand owing to the coronavirus-led pantry loading. We have selected five stocks with an earnings beat potential.
Coty's (COTY) Earnings Miss Estimates in Q3, Sales Down
by Zacks Equity Research
Weakness across all segments stemming from coronavirus-induced lockdowns hurt Coty's (COTY) top line in third-quarter fiscal 2020.
Coty (COTY) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Coty (COTY) delivered earnings and revenue surprises of -700.00% and 0.94%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Cosmetics Industry Outlook Prospects Dimmed by Coronavirus Woes
by Vrishali Bagree
The Cosmetics space appears to be under pressure, thanks to coronavirus-led concerns like major travel restrictions, delay in product launches and temporary store closures in some regions.
How Damaging Has Coronavirus Been to Coty's (COTY) Q3 Earnings?
by Zacks Equity Research
The coronavirus impact and soft Consumer Beauty segment have most likely marred third-quarter fiscal 2020 performance.
Earnings Preview: Coty (COTY) Q3 Earnings Expected to Decline
by Zacks Equity Research
Coty (COTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Options Traders Betting on a Big Move in Coty Stock?
by Zacks Equity Research
Investors need to pay close attention to Coty stock based on the movements in the options market lately.
Coty (COTY) Jumps: Stock Rises 7.5%
by Zacks Equity Research
Coty (COTY) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Will Nu Skin Mainland China Woes Worsen Due to Coronavirus?
by Zacks Equity Research
Nu Skin (NUS) anticipates sales in Mainland China to decline 20-25% in 2020. The company puts meetings on hold in the region due to the coronavirus outbreak.
Coty (COTY) Down 26.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Coty (COTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.